DIA Europe 2027
By DIA
Why it matters: European regulatory and HTA dialogue includes a value-and-access track and payer participation.
MORSE events and selected market-access events from around the world.
Find a MORSE programme or a selected industry event.
Relevant market-access, reimbursement and HTA events, selected for their value to the field.
March 2027
By DIA
Why it matters: European regulatory and HTA dialogue includes a value-and-access track and payer participation.
April 2027
By Health Technology Assessment international (HTAi)
Why it matters: Regional HTA policy dialogue among health-system leaders, HTA agencies, industry and patient representatives; attendance is by application.
May 2027
By ISPOR
Why it matters: International HEOR meeting on evidence, policy, value and access decisions.
June 2027
By Health Technology Assessment international (HTAi)
Why it matters: International HTA and evidence-to-decision practice.
September 2027
By Terrapinn
Why it matters: Dedicated US congress on pharmaceutical pricing, market access, evidence and reimbursement.
By Canada’s Drug Agency (CDA-AMC)
Why it matters: The national HTA agency’s evidence and health-system forum; 2027 programme and registration have not been published.
October 2027
By ACCESS Forum
Why it matters: European market-access forum for pharmaceutical, payer, HTA and patient-organization leaders; programme and registration details are pending.
November 2027
By ISPOR
Why it matters: International HEOR conference with evidence-to-decision relevance; programme detail still needs editorial review.
No external events are currently approved for this list.
Event details may change. Check the organizer’s page for the latest information.